JP2024523406A5 - - Google Patents
Info
- Publication number
- JP2024523406A5 JP2024523406A5 JP2023577946A JP2023577946A JP2024523406A5 JP 2024523406 A5 JP2024523406 A5 JP 2024523406A5 JP 2023577946 A JP2023577946 A JP 2023577946A JP 2023577946 A JP2023577946 A JP 2023577946A JP 2024523406 A5 JP2024523406 A5 JP 2024523406A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- human subject
- use according
- administered
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108523.8A GB202108523D0 (en) | 2021-06-15 | 2021-06-15 | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |
| GB2108523.8 | 2021-06-15 | ||
| PCT/GB2022/051502 WO2022263816A1 (en) | 2021-06-15 | 2022-06-15 | COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523406A JP2024523406A (ja) | 2024-06-28 |
| JP2024523406A5 true JP2024523406A5 (enExample) | 2025-06-20 |
| JP7854001B2 JP7854001B2 (ja) | 2026-04-30 |
Family
ID=76954605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577946A Active JP7854001B2 (ja) | 2021-06-15 | 2022-06-15 | α１－アンチトリプシン欠乏症の処置のための組成物およびそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12673050B2 (enExample) |
| EP (1) | EP4355328A1 (enExample) |
| JP (1) | JP7854001B2 (enExample) |
| KR (1) | KR20240027693A (enExample) |
| CN (1) | CN117794538A (enExample) |
| AU (1) | AU2022295130A1 (enExample) |
| BR (1) | BR112023026510A2 (enExample) |
| CA (1) | CA3223130A1 (enExample) |
| GB (1) | GB202108523D0 (enExample) |
| IL (1) | IL309355A (enExample) |
| MX (1) | MX2023015398A (enExample) |
| WO (1) | WO2022263816A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201918410D0 (en) | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of alpha1-antitrypsin deficiency |
| GB202108523D0 (en) | 2021-06-15 | 2021-07-28 | Z Factor Ltd | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
| JP3391038B2 (ja) | 1991-12-26 | 2003-03-31 | 富士レビオ株式会社 | カルボン酸アミド誘導体 |
| WO2005113542A2 (en) | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| WO2008143633A2 (en) | 2007-01-10 | 2008-11-27 | University Of Florida | Compounds and methods for treatment of alpha-1 antitrypsin deficiency |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| US8258158B2 (en) | 2009-09-11 | 2012-09-04 | Hoffmann-La Roche Inc. | HSL inhibitors useful in the treatment of diabetes |
| WO2011110852A1 (en) | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
| WO2012097371A2 (en) * | 2011-01-14 | 2012-07-19 | The Regents Of The University Of California | Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis |
| CN110325527B (zh) | 2016-12-09 | 2022-08-09 | 勃林格殷格翰国际有限公司 | 作为细胞外柠檬酸盐摄取的抑制剂的磺酰胺 |
| CA3103920C (en) | 2018-06-22 | 2025-09-16 | Ucl Business Ltd | COMPOUNDS FOR TREATING DISEASES MEDIATED BY ALPHA-1 ANTITRYPSIN |
| JOP20210060A1 (ar) | 2018-10-05 | 2023-01-30 | Vertex Pharma | معدلات لمضاد تريبسين ألفا-1 |
| US11884672B2 (en) | 2019-05-14 | 2024-01-30 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| GB201918410D0 (en) * | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of alpha1-antitrypsin deficiency |
| GB202108523D0 (en) | 2021-06-15 | 2021-07-28 | Z Factor Ltd | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |
-
2021
- 2021-06-15 GB GBGB2108523.8A patent/GB202108523D0/en not_active Ceased
-
2022
- 2022-06-15 CN CN202280053656.2A patent/CN117794538A/zh active Pending
- 2022-06-15 IL IL309355A patent/IL309355A/en unknown
- 2022-06-15 MX MX2023015398A patent/MX2023015398A/es unknown
- 2022-06-15 JP JP2023577946A patent/JP7854001B2/ja active Active
- 2022-06-15 WO PCT/GB2022/051502 patent/WO2022263816A1/en not_active Ceased
- 2022-06-15 CA CA3223130A patent/CA3223130A1/en active Pending
- 2022-06-15 KR KR1020247001332A patent/KR20240027693A/ko active Pending
- 2022-06-15 BR BR112023026510A patent/BR112023026510A2/pt unknown
- 2022-06-15 AU AU2022295130A patent/AU2022295130A1/en active Pending
- 2022-06-15 EP EP22735956.9A patent/EP4355328A1/en active Pending
-
2023
- 2023-12-14 US US18/540,695 patent/US12673050B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540183A5 (enExample) | ||
| JP2022191257A5 (enExample) | ||
| CN100528151C (zh) | 莫达非尼药物剂型 | |
| KR101653071B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2024170583A5 (enExample) | ||
| WO2011069326A1 (zh) | 包含阿替洛尔和氨氯地平的双层片剂 | |
| JP2015526458A5 (enExample) | ||
| CN100577171C (zh) | 治疗重度心力衰竭的药物 | |
| RU2720204C1 (ru) | Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола | |
| CN109952101A (zh) | 治疗高细胞因子血症和病毒感染的肥大细胞稳定剂 | |
| JP2024515829A5 (enExample) | ||
| RU2286784C2 (ru) | Таблетка, содержащая цетиризин и псевдоэфедрин | |
| ES2389539T3 (es) | Métodos y composiciones para el tratamiento del asma | |
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2019533660A5 (enExample) | ||
| JP2022536623A (ja) | 肺動脈性肺高血圧症の治療方法 | |
| JP2024523559A5 (enExample) | ||
| JP5941258B2 (ja) | 他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール | |
| JP2023523706A5 (enExample) | ||
| JP2023553253A5 (enExample) | ||
| JP2023509698A5 (enExample) | ||
| JP2025517509A5 (enExample) | ||
| JP2019502734A (ja) | 手湿疹の治療 | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa |